Cited by 21Neurogenesis and neuroplasticity mechanismsCell death mechanisms and regulationNeuroinflammation and Neurodegeneration Mechanisms

Maintenance of the relative proportion of oligodendrocytes to axons even in the absence of BAX and BAK

Open access
Kawai, Kumi, Itoh, Takayuki, Itoh, Aki, Horiuchi, Makoto, Wakayama, Kouji, Bannerman, Peter, Garbern, James Y., Pleasure, David +1 more·2009·European Journal of Neuroscience

Abstract

Highly purified oligodendroglial lineage cells from mice lacking functional bax and bak genes were resistant to apoptosis after in-vitro differentiation, indicating an essential role of the intrinsic apoptotic pathway in apoptosis of oligodendrocytes in the absence of neurons (axons) and other glial cells. These mice therefore provide a valuable tool with which to evaluate the significance of the intrinsic apoptotic pathway in regulating the population sizes of oligodendrocytes and oligodendroglial progenitor cells. Quantitative analysis of the optic nerves and the dorsal columns of the spinal cord revealed that the absolute numbers of mature oligodendrocytes immunolabeled for aspartoacylase and adult glial progenitor cells expressing NG2 chondroitin sulfate proteoglycan were increased in both white matter tracts of adult bax/bak-deficient mice and, to a lesser extent, bax-deficient mice, except that there was no increase in NG2-positive progenitor cells in the dorsal columns of these strains of mutant mice. These increases in mature oligodendrocytes and progenitor cells in bax/bak-deficient mice were unexpectedly proportional to increases in numbers of axons in these white matter tracts, thus retaining the oligodendroglial lineage to axon ratios of at most 1.3-fold of the physiological numbers. This is in contrast to the prominent expansion in numbers of neural precursor cells in the subventricular zones of these adult mutant mice. Our study indicates that homeostatic control of cell number is different for progenitors of the oligodendroglial and neuronal lineages. Furthermore, regulatory mechanism(s) operating in addition to apoptotic elimination through the intrinsic pathway, appear to prevent the overproduction of highly mitotic oligodendroglial progenitor cells.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1460-9568.2009.06988.x

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ASPA is a marker of mature oligodendrocytes, and ASPA+ cells overlap 100% with GSTπ and 93% with CC1.

    “ASPA is a marker of mature oligodendrocytes. In this population, ASPA positive cells have been reported to overlap 100 and 93% with the widely used oligodendrocyte soma markers glutathione S-transferase π isoform and CC1, respectively (Kawai et al., 2009).”

    From Recombinant Human Myelin-Associated Glycoprotein Promoter Drives Selective AAV-Mediated Transgene Expression in Oligodendrocytes (2016) · cites this paper as Kawai et al., 2009

    The Results section reports that ASPA marks mature oligodendrocytes and that ASPA-positive cells overlapped with almost 100% of GSTπ-positive cells and 93 ± 4% of CC1-positive cells in three adult mice. The citing sentence makes the first figure an exact 100% and omits the uncertainty around the second. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kawai, K., Itoh, T., Itoh, A., Horiuchi, M., Wakayama, K., Bannerman, P., Garbern, J. Y., Pleasure, D., & Lindsten, T.
Affiliations
  • Shriners Hospitals for Children - Northern California (US)
  • Wayne State University (US)
  • University of Pennsylvania (US)
Corresponding author
Itoh, Aki
Venue
European Journal of Neuroscience
Publisher
Wiley
Published
2009-11-30
Volume
30
Issue
11
Pages
2030-2041
ISSN
  • 0953-816X (ISSN-L)
  • 1460-9568
OpenAlex
W2069025840
Cited by
21
References
46
Citations by year
2026: 1 · 2025: 1 · 2022: 2 · 2021: 2 · 2020: 3 · 2018: 2 · 2016: 3 · 2014: 2 · 2013: 1 · 2012: 1
FWCI
0.42
Type
journal article
Language
en
Open access
Locations
  • European Journal of Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Neurological Disorders and Stroke (NS025044, R01NS025044)
Topics
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
oligodendrocytes, axons, Bax, Bak, mitochondrial apoptosis, apoptosis, aspartoacylase, white matter, optic nerve, spinal cord dorsal columns, glial lineage
MeSH terms
Chondroitin Sulfate Proteoglycan 4, Animals, Animals, Newborn, Antigens, Axons, Brain, Cell Differentiation, Cells, Cultured, Myelin Basic Protein, Gangliosides, Gene Expression Regulation, Myelin Sheath, Oligodendroglia, Optic Nerve, Proteoglycans, RNA, Messenger, Stem Cells, Time Factors, Cell Death, Apoptosis, Mice, Knockout, O Antigens, In Situ Nick-End Labeling, bcl-2 Homologous Antagonist-Killer Protein, bcl-2-Associated X Protein, Mice, Proto-Oncogene Proteins c-bcl-6

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review